Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension

NCT01096381 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT01096381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01096381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Trial Evaluating Potential Biomarkers for Bevacizumab Induced Hypertension
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Terminated
Start date
March 31, 2010
Completion date
August 31, 2011
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiovascular complications, colorectal cancer, fallopian tube cancer, head and neck cancer, lung cancer, ovarian cancer, peritoneal cavity cancer, unspecified adult solid tumor, protocol specific